Subscribe
  • Redeem your points

Search

Primary links

  • Home
  • Companies
    Biotechnology Semiconductors Consumer Products and Services
    Industrial/Energy Medical Devices and Equipment Media and Entertainment IT Services Networking and Equipment Electronics/Instrumentation Software Wireless Financial Services Telecommunications Computers and Peripherals Retailing/Distribution Business Products and Services Healthcare Services Other
  • Press
  • Jobs
  • Blogs
    Apple Mobile
    Business Dev & Design Entertainment Social Media Tech Web Video
  • Videos
    Apple Mobile
    Business Dev & Design Entertainment Social Media Tech Web Video
  • Forum

EyeGate Pharmaceuticals Inc

EyeGate Pharmaceuticals Inc

Average: 5 (1 vote)

Develops medicine to treat diseases of the eye.

Year Established:
Funding: 47.6
Address:

EyeGate Pharma 100 Beaver Street Waltham, MA 02453

Telephone:
Mobile:
Fax:
Mail: info@eyegatepharma.com
Company URL: http://www.eyegatepharma.com

blocks_tabs

  • Job Listings
  • Press Releases
  • Industry Experts
  • Tech Community Rating
  • Investors
  • Management Team

The EyeGate Environment

The expertise motivation and creativity of each person at EyeGate Pharma contribute to our success. We are committed to hiring smart and motivated persons as we grow to our next phase of development.

EyeGate provides a stimulating work environment with career opportunities in both Europe and the U.S.

We are looking for more great people to join our venture - specifically high energy candidates with solid performance backgrounds creative ideas and a commitment to excellence. Our cohesive environment fosters individual successes as well as team accomplishments.

If you share the same vision as we do at EyeGate Pharma and are interested in joining the EyeGate team please forward your resume to hr@eyegatepharma.com.

2010

3/25/10
EyeGate Pharma Completes Phase II Study of EGP-437 in Patients with Anterior Uveitis

1/8/10
EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrome

User
5
viresh

Emerging ISV Capital Partners,Innoven Partenaires S.A.,Medicis AG,Natixis-Cape SGR SpA (AKA:Cimino & Associati Private Equity),New England Partners,Undisclosed Firm,Ventech S.A.

J. Cleftie
Director
Michael Mullen
Director
Paul Chaney
Director
Praveen Tyle
Director
Alain Maiore
Director
Thomas Hancock
Director
Morton Goldberg
Director

  • Home
  • Companies
  • Biotechnology
  • IT Industry
  • Industrial/Energy
  • Medical Devices and Equipment
  • Media and Entertainment
  • IT Services
  • Networking and Equipment
  • Semiconductors
  • Electronics/Instrumentation
  • Software
  • Wireless
  • Financial Services
  • Telecommunications
  • Consumer Products and Services
  • Computers and Peripherals
  • Retailing/Distribution
  • Business Products and Services
  • Healthcare Services
  • Other
  • Press
  • Blogs
  • Blogs
  • Apple
  • Business
  • Dev & Design
  • Entertainment
  • Mobile
  • Social Media
  • Tech
  • Web Video
  • Videos
  • Apple
  • Business
  • Dev & Design
  • Entertainment
  • Mobile
  • Social Media
  • Tech
  • Web Video
  • Forum
  • Home
  • Companies
  • Biotechnology
  • Industrial/Energy
  • Medical Devices and Equipment
  • Media and Entertainment
  • IT Services
  • Networking and Equipment
  • Semiconductors
  • Electronics/Instrumentation
  • Software
  • Wireless
  • Financial Services
  • Telecommunications
  • Consumer Products and Services
  • Computers and Peripherals
  • Retailing/Distribution
  • Business Products and Services
  • Healthcare Services
  • Other
  • Press
  • Blogs